HQY — HealthEquity, Inc.

HealthEquity, Inc. (HQY) Q4 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: $334.6 million, up 7% year-over-year.
• Net Income: $49.7 million, a significant increase of 89% year-over-year.
• Non-GAAP Net Income: $81.8 million, up 33%, with non-GAAP earnings per share at $0.95 (up 38%).
• Adjusted EBITDA: $132.9 million, reflecting a 23% growth and a margin expansion to 40%.
• Total HSAs: 17.8 million accounts, with a record addition of 550,000 in Q4 and over 1 million for the year.
• HSA Assets: Exceeded $36 billion, a 14% increase year-over-year.
• Share Repurchase: Over $300 million returned to shareholders in fiscal 2026, reducing diluted shares by approximately 3%.

2. Strategic Updates and Business Highlights

• Engagement and Technology: Strong focus on enhancing member engagement through a mobile platform, with over 3.6 million app downloads. The company is leveraging AI to improve member experience and operational efficiency.
• Marketplace Launch: Introduced a marketplace for health-related products and services, with initial offerings in weight-loss programs, hormone replacement therapy, and healthcare wearables. Early adoption shows promising retention rates.
• Regulatory Environment: Positive changes in HSA eligibility due to the Working Families Tax Cut Act, expanding access to HSAs for individuals on ACA exchanges.
• Fraud Management: Achieved a fraud reimbursement rate of approximately 0.1 basis points, significantly below the target of 1 basis point.

3. Forward Guidance and Outlook

• Fiscal 2027 Revenue Guidance: Expected between $1.405 billion and $1.415 billion.
• GAAP Net Income Guidance: Projected between $239 million and $246 million, or $2.78 to $2.85 per share.
• Non-GAAP Net Income Guidance: Expected between $392 million and $400 million, or $4.56 to $4.65 per share.
• Adjusted EBITDA Guidance: Anticipated between $618 million and $628 million.
• Interest Rate Outlook: Average yield on HSA cash expected to be approximately 3.8% for fiscal 2027.

4. Bad News, Challenges, or Points of Concern

• Market Conditions: The company is navigating a challenging macroeconomic environment with slower job growth (181,000 jobs added in the U.S.) which could impact future growth.
• Dependence on Legislative Changes: While recent policy changes are favorable, the company’s growth strategy is somewhat reliant on ongoing legislative support for HSAs.
• Competitive Landscape: Despite strong retention rates (over 98%), there is ongoing competition in the HSA space, and the company must continue to innovate to maintain its market position.

5. Notable Q&A Insights

• Gross Margin Potential: Analysts inquired about the sustainability of gross margin expansion, with management expressing confidence in continued improvements through operational efficiencies and AI initiatives.
• Marketplace Engagement: Early trends in marketplace offerings suggest positive engagement, with members showing interest in programs, although it is still early to quantify long-term impacts.
• ACA Cohort Performance: Management noted that it is too early to assess the long-term performance of members coming from ACA bronze plans, but initial contributions are encouraging.
• Interest Rate Impact: Concerns were raised about the potential impact of declining interest rates on custodial revenue, with management clarifying that the effects would be gradual and already factored into their guidance.

Overall, HealthEquity, Inc. demonstrated strong financial performance in Q4 2026, with a positive outlook for fiscal 2027 driven by strategic initiatives and favorable regulatory changes, despite facing challenges from market conditions and competition.